PrEP will be available for 10,000 people across the country. NHS England have launched their long-awaited three-year trial of HIV-prevention drugs in the hopes of significantly reducing the number of people acquiring the virus.
PrEP – Pre-Exposure Prophylaxis – is an anti-HIV medication taken by people who are HIV negative to lower their risk of contracting the infection. NHS England will be using the drug Truvada for their trial, giving it out to groups of people considered to be at high risk of exposure to HIV for free.
London’s 10 Hammersmith Broadway began enrolment yesterday, with 56 Dean Street in Soho expected to start theirs today. A full list of clinics taking part in the trial will be available online on the IMPACT website in the coming weeks.
“The PrEP Impact Trial aims to answer key questions about the use of PrEP by groups at a higher need in England. The trial is planned to last three years and enrol 10,000 participants at high risk of acquiring HIV,” the website explains. Read more via Gay Times